SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-17
👔
Cue Biopharma, Inc.
@CUE_InsiderForm 4 Filing: Ray Sumita Sells $266K of $CUE
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Cue Biopharma, Inc.
Ticker: $CUE
Transaction Value
$266K
Price/Share: $9.83
transaction date
2026-08-13
Shares: 27,025
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Ray Sumita, holds the title of Chief Legal Compliance Officer at Cue Biopharma, Inc..
On 2026-08-13, the insider transacted 27,025 shares.The shares were transacted at a weighted average price of $9.83 per share, resulting in a total market-relevant value of $266K.
Executive Summary Summary
Ray Sumita (Chief Legal Compliance Officer) sold $266K of $CUE
Post-Transaction Position: 118,549 shares
SEC Accession No: 0001579629-26-000008 (CIK: 1579629)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.